Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

A través dels grups de recerca de Malalties Infeccioses i de Microbiologia, participem en assaigs clínics per trobar nous esquemes terapèutics per a les persones amb tuberculosi.

The work of the Microbiology group of VHIR will optimize a diagnostic algorithm for the screening of hepatitis D virus infection in Barcelona.

The variants of the virus at the beginning of the pandemic presented defective genomes in the spike gene, that is, some viral particles lacked part of the key genomic material to infect new cells.

The scientific review reports that changes in the respiratory system flora due to pollution increase the risk of suffering a hospital infection caused by multidrug-resistant organisms.

Els ajuts impulsaran estudis en els camps del VIH, les hepatitis virals i la COVID-19.

The research, published in The Lancet, studied patients in Barcelona and Madrid, and shows that direct contact is the main route of transmission for the disease.

Vall d'Hebron is one of the participants in the CARB-ES-19 research, led by the CIBER, in which 71 hospitals throughout the peninsula have collaborated.

The researcher Carles Rubio presented the research of the VHIR Microbiology research group and the UPC and co-funded by the Probitas Foundation.

The new nano-biosensor for fast, quantitative and accurate COVID-19 serology achieves the high reliability of specialised laboratory analysis with the short times and simplicity of rapid self-tests.

This year, the Vall d'Hebron team has participated in the publication of three articles to understand the 2016 enterovirus A71 (EV-A71) outbreak in Catalonia and the follow-up of non-polio enteroviruses today.